BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price fell 12.9% during trading on Wednesday . The stock traded as low as $1.96 and last traded at $2.00. 198,227 shares changed hands during trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $2.29.
BioRestorative Therapies Stock Performance
The stock’s fifty day simple moving average is $1.90 and its two-hundred day simple moving average is $1.69. The stock has a market capitalization of $3.27 billion, a P/E ratio of -1.86 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- Stock Dividend Cuts Happen Are You Ready?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is the Dogs of the Dow Strategy? Overview and Examples
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Find and Profitably Trade Stocks at 52-Week Lows
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
